OEHHA request for relevant information on carcinogenicity of ethoprop (potential delisting review)

OEHHA issued a request for relevant information regarding the carcinogenicity of ethoprop as part of the Proposition 65 Carcinogen Identification Committee (CIC) process, indicating a potential delisting review pathway. Compliance teams that manufacture, distribute, or sell products that may involve ethoprop should monitor this review because a future delisting decision could change warning obligations, but no delisting has occurred at this stage.